TCEAL7 was identified to be frequently downregulated in tumors as compared with the corresponding normal tissues, such as ovarian cancer, endometrial carcinoma and gastric adenocarcinoma [4, 6, 19]. Here, TCEAL7 is linked to ovarian carcinoma.